Evidence mapPaperPMID 37169495Full record

ArticleBMJ open2023

Cluster randomised trial to evaluate comprehensive approach to hypertension management in Nepal: a study protocol.

Sanju Bhattarai, Archana Shrestha, Eva Skovlund, Bjørn Olav Åsvold, Bente Prytz Mjølstad, Abhijit Sen

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05292469 (A Cluster Randomized Trial to Evaluate Comprehensive Approach to Hypertension Management in Nepal), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05292469 nacompletednot on this map

A Cluster Randomized Trial to Evaluate Comprehensive Approach to Hypertension Management in Nepal

TypeinterventionalSponsorNorwegian University of Science and TechnologyRan2022 to 2023Enrolled1,252ConditionsHypertensionArmsComprehensive approach to hypertension management
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sanju BhattaraiDepartment of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway sanju.bhattarai@ntnu.no.ORCID 0000-0003-4246-9117
Archana ShresthaInstitute for Implementation Science and Health, Kathmandu, Nepal.ORCID 0000-0002-4741-090X
Eva SkovlundDepartment of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Bjørn Olav ÅsvoldDepartment of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Bente Prytz MjølstadDepartment of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Abhijit SenDepartment of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0001-9560-4226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDespite having effective approaches for hypertension management including use of antihypertensive medication, monitoring of blood pressure and lifestyle modification many people with hypertension in Nepal remain undetected and untreated. A comprehensive intervention which provides personalised counselling on lifestyle modification, medication adherence together with support for regular monitoring of blood pressure is expected to achieve well controlled blood pressure. METHODS AND ANALYSIS: This is a community-based, non-blinded, parallel group, two-arm cluster randomised controlled trial, with an allocation ratio of 1:1, conducted in Budhanilkantha municipality, Nepal. Ten health facilities and their catchment area are randomly allocated to either of the two arms. 1250 individuals aged 18 years and older with an established diagnosis of hypertension will be recruited. The intervention arm receives a comprehensive hypertension management package that includes blood pressure audit by health workers, home-based patient support by community health workers to engage patient and family members in providing tailored educational counselling on behavioural and lifestyle changes in addition to routine care. The control arm includes routine hypertension care. Trained enumerators will ensure consent and collect data. Outcome data on blood pressure, weight, waist and hip circumference will be measured and self-reported data on diet, lifestyle, medication adherence and hypertension knowledge will be registered at 11 months' follow-up. The change in outcome measures will be compared by intention to treat, using a generalised linear mixed model. A formative assessment will be conducted using semistructured interviews and focus group discussions to explore factors affecting hypertension management. A mix-method approach will be applied for process evaluation to explore acceptability, adoption, fidelity, feasibility and coverage. ETHICS AND DISSEMINATION: Ethics approval was obtained from Nepal Health Research Council (682/2021) and Regional Committee for Medical and Health Research Ethics, Norway (399479). The findings will be disseminated in peer-reviewed journal articles and with decision makers in Nepal.

Indexed as

HypertensionAntihypertensive AgentsBlood PressureCounselingHumansNepalRandomized Controlled Trials as TopicAntihypertensive AgentsEPIDEMIOLOGYHypertensionPUBLIC HEALTH

Identifiers

PMID37169495
PMCPMC10186459

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.